Literature DB >> 16905711

Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution.

A Perrella, L Vitiello, L Atripaldi, P Conti, C Sbreglia, S Altamura, T Patarino, R Vela, G Morelli, P Bellopede, C Alone, L Racioppi, O Perrella.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16905711      PMCID： PMC1860041          DOI： 10.1136/gut.2006.099887

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

1.  Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial.

Authors:  Hideyuki Nomura; Suketo Sou; Hironori Tanimoto; Takashi Nagahama; Yoichi Kimura; Jun Hayashi; Hiromi Ishibashi; Seizaburo Kashiwagi
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

2.  Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis.

Authors:  Maria Serena Longhi; Yun Ma; Ragai R Mitry; Dimitrios P Bogdanos; Michael Heneghan; Paul Cheeseman; Giorgina Mieli-Vergani; Diego Vergani
Journal:  J Autoimmun       Date:  2005-08       Impact factor: 7.094

3.  Flow cytometry assay of myeloid dendritic cells (mDCs) in peripheral blood during acute hepatitis C: possible pathogenetic mechanisms.

Authors:  Alessandro Perrella; Luigi Atripaldi; Pasquale Bellopede; Tommaso Patarino; Costanza Sbreglia; Giovanni Tarantino; Paolo Sorrentino; Paolo Conca; Luca Ruggiero; Oreste Perrella
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

4.  Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease.

Authors:  Thomas W Yoo; Sharyne Donfield; Alice Lail; Henry S Lynn; Eric S Daar
Journal:  J Infect Dis       Date:  2004-12-02       Impact factor: 5.226

5.  Projecting future complications of chronic hepatitis C in the United States.

Authors:  Gary L Davis; James E Albright; Suzanne F Cook; Daniel M Rosenberg
Journal:  Liver Transpl       Date:  2003-04       Impact factor: 5.799

Review 6.  Immunology of hepatitis B virus and hepatitis C virus infection.

Authors:  Barbara Rehermann; Michelina Nascimbeni
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

7.  An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.

Authors:  Roniel Cabrera; Zhengkun Tu; Yiling Xu; Roberto J Firpi; Hugo R Rosen; Chen Liu; David R Nelson
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

8.  Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.

Authors:  Maria Serena Longhi; Yun Ma; Dimitrios P Bogdanos; Paul Cheeseman; Giorgina Mieli-Vergani; Diego Vergani
Journal:  J Hepatol       Date:  2004-07       Impact factor: 25.083
  8 in total
  10 in total

1.  Ribavirin modulates the conversion of human CD4(+)  CD25(-) T cell to CD4(+)  CD25(+)  FOXP3(+) T cell via suppressing interleukin-10-producing regulatory T cell.

Authors:  Tamaki Kobayashi; Katsuhisa Nakatsuka; Masumi Shimizu; Hideto Tamura; Eiji Shinya; Masanori Atsukawa; Hirotomo Harimoto; Hidemi Takahashi; Choitsu Sakamoto
Journal:  Immunology       Date:  2012-11       Impact factor: 7.397

2.  HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-beta.

Authors:  Caroline H T Hall; Rachel Kassel; Robert S Tacke; Young S Hahn
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

Review 3.  T cells with regulatory activity in hepatitis C virus infection: what we know and what we don't.

Authors:  Angela Dolganiuc; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2008-05-21       Impact factor: 4.962

Review 4.  Immune responses and immunopathology in acute and chronic viral hepatitis.

Authors:  Eui-Cheol Shin; Pil Soo Sung; Su-Hyung Park
Journal:  Nat Rev Immunol       Date:  2016-07-04       Impact factor: 53.106

Review 5.  Autoimmune manifestations in viral hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  Semin Immunopathol       Date:  2012-07-28       Impact factor: 11.759

6.  A study of the immunoloregulation of double filtration plasmapheresis in maintenance hemodialysis patients with chronic hepatitis C.

Authors:  Hongdi Cao; Ping Wen; Hong Ye; Zhiping Sun; Xia Shen; Xiaochun Wu; Chunsun Dai; Junwei Yang
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

7.  Indoleamine 2,3-dioxygenase expression and activity in patients with hepatitis C virus-induced liver cirrhosis.

Authors:  Kashif Asghar; M Taimour Ashiq; Bilal Zulfiqar; Amnah Mahroo; Kaenat Nasir; Sheeba Murad
Journal:  Exp Ther Med       Date:  2014-12-18       Impact factor: 2.447

Review 8.  Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma.

Authors:  Kashif Asghar; Asim Farooq; Bilal Zulfiqar; Muhammad Usman Rashid
Journal:  World J Gastroenterol       Date:  2017-04-07       Impact factor: 5.742

9.  Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study.

Authors:  Luca Rinaldi; Alessandro Perrella; Maria Guarino; Massimo De Luca; Guido Piai; Nicola Coppola; Pia Clara Pafundi; Fortunato Ciardiello; Morena Fasano; Erika Martinelli; Giovanna Valente; Riccardo Nevola; Caterina Monari; Lucia Miglioresi; Barbara Guerrera; Massimiliano Berretta; Ferdinando Carlo Sasso; Filomena Morisco; Antonio Izzi; Luigi Elio Adinolfi
Journal:  J Transl Med       Date:  2019-08-28       Impact factor: 5.531

10.  Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells.

Authors:  Angela Dolganiuc; Karen Kodys; Christopher Marshall; Banishree Saha; Shuye Zhang; Shashi Bala; Gyongyi Szabo
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.